Dr. Carole Bourquin

Biography

Carole Bourquin is a distinguished professor and institute director specializing in pharmacology. Holding a full professorship at the University of Bern, Bourquin also oversees clinical pharmacology at the Inselspital Bern. She studied medicine in Geneva and earned her doctorate in Immunology at the Max Planck Institute in Munich. Establishing her own research group at Ludwig Maximilian University of Munich, she focused on cancer immunotherapy. In 2011, she returned to Switzerland, taking a full professorship at the University of Fribourg. Since 2016, she has held a professorship at the University of Geneva while practicing as a clinical pharmacologist. Bourquin leads the translational research center in oncohaematology and is set to lead the Institute of Pharmacology at the University of Bern in 2024. Her research bridges fundamental science and clinical application with a focus on enhancing antitumor immunity through pharmacological strategies. She is known for her contributions to immunopharmacology and drug development, particularly in enhancing the immune system's ability to fight cancer. Her team investigates the role of lipid metabolism in anti-tumor immune responses and explores nanoparticle-based drug delivery systems to improve therapeutic efficacy.

Research Interests